MetaCap

Materion (MTRN) vs Zimmer Biomet (ZBH)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.

Summary

Materion (MTRN) has outperformed Zimmer Biomet (ZBH) over the past year, gaining 118.4% versus a loss of 9.6%. Over five years, MTRN leads with a +284.3% price change compared with -37.5% for ZBH. Zimmer Biomet is the larger company by market cap ($17.00 billion vs $5.84 billion), about 2.9 times the size.

On valuation, Zimmer Biomet trades at a lower forward P/E (9.8x vs 33.3x for Materion). Zimmer Biomet offers the higher dividend yield (1.08% vs 0.20%). Zimmer Biomet converts more of its revenue into profit, with a net margin of 8.6% versus 4.2%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

MTRN+118.44%ZBH-9.64%
+160%+66%-28%
Oct 8, 20251 yearOct 8, 2026
MTRN+292.67%ZBH-37.57%
+362%+150%-61%
Oct 4, 20215 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

MTRN versus ZBH key metrics
MetricMTRNZBH
Share price$280.45$89.14
Market cap$5.84B$17.00B
1-day change+1.21%+0.29%
YTD return+122.90%-1.16%
1-year return+118.44%-9.64%
5-year return+284.29%-37.45%
P/E ratio (TTM)65.3721.64
Forward P/E33.259.83
EPS (TTM)$4.29$4.12
Dividend yield0.20%1.08%
Annual dividend$0.565$0.96
Revenue (latest FY)$1.79B$8.23B
Revenue growth (YoY)+6.04%+7.20%
Net income (latest FY)$74.82M$705.10M
Gross margin17.27%69.71%
Operating margin6.15%13.34%
Net margin4.19%8.57%
52-week high$324.99$106.88
52-week low$109.61$79.12
Distance from 52-week high-13.71%-16.60%
Analyst consensusbuybuy
Avg. price target upside+8.31%+20.29%
Average volume315.57K2.17M
Shares outstanding20.83M190.74M
Employees3,00017,000
SectorIndustrialsHealth Care
IndustryIndustrial SpecialtiesIndustrial Specialties

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Zimmer Biomet is about 2.9 times larger than Materion by market value ($17.00B vs $5.84B).
  • MTRN has outperformed ZBH by 128.1 percentage points over the past year.
  • Materion trades at a higher earnings multiple (65.4x vs 21.6x trailing P/E).
  • The two companies sit in different sectors: Materion in Industrials and Zimmer Biomet in Health Care.

About Materion

MTRN stock →

Materion Corporation, together with its subsidiaries, produces advanced engineered materials in the United States, Asia, Europe, and internationally. The company operates in four segments: Performance Materials, Electronic Materials, Precision Optics, and Other.

Industrials · Industrial Specialties · 3,000 employees

About Zimmer Biomet

ZBH stock →

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T.

Health Care · Industrial Specialties · 17,000 employees

MTRN vs ZBH FAQ

Which is bigger, Materion or Zimmer Biomet?

Zimmer Biomet (ZBH) is larger, with a market capitalization of $17.00B compared with $5.84B for Materion (MTRN).

Which stock has performed better over the past year, MTRN or ZBH?

MTRN returned +118.44% over the past 12 months, compared with -9.64% for ZBH (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, MTRN or ZBH?

ZBH has the lower trailing P/E at 21.6, versus 65.4 for MTRN. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Which pays a higher dividend, Materion or Zimmer Biomet?

Zimmer Biomet has the higher yield at 1.08%, compared with 0.20% for Materion.

Are Materion and Zimmer Biomet in the same industry?

Yes. Both are classified in the Industrial Specialties industry within the Industrials sector.

More comparisons